Although several studies have shown that PI3K inhibitors obstruct the migration of prostate cancer cells as induced by chemical mediators, those studies assumed that PI3K affected the upstream signal transduction of Rac1 [32]–[34]. The gene discussed is RAC1; the disease is Familial prostate cancer.